(METX) |
| 0 (0%) 10-29 16:05 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 10.50 |
| Resistance 1: | 8.99 |
| Pivot price: | 8.09 |
| Support 1: | 7.32 |
| Support 2: | 6.29 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 3710000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.96 |
| Gross Profit | 5.000 |
| Profit Margin (%) | -6.90 |
| Operating Margin (%) | 3.75 |
| Return on Assets (ttm) | 5.6 |
| Return on Equity (ttm) | -1.0 |
Company news
Wed, 21 Oct 2026
ME Therapeutics Holdings, Inc. (CN:METX) Extends Bullish Momentum as Investor Interest Strengthens - kalkine.ca
Mon, 19 Oct 2026
Why CN:METX sank on the CSE: a handful of thin trades knocked ME Therapeutics lower after its CD22 option extension - kalkine.ca
Fri, 16 Oct 2026
ME Therapeutics Holdings, Inc. (CN:METX) Jumps 12.50% as Positive Momentum Lifts Investor Interest - kalkine.ca
Thu, 15 Oct 2026
ME Therapeutics Holdings (CN:METX) Drops 42.86%: Preclinical Biotech Risks and Dilution Uncertainty Weigh on Sentiment - kalkine.ca
Fri, 17 Jul 2026
ME Therapeutics Closes Over-Subscribed Private Placement - Business Wire
Tue, 26 Nov 2024
Metanyx (METX) Price Today, News & Live Chart | Forbes Crypto Market Data - Forbes
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
